MET-PF — MetLife, Inc.

MetLife (MET-PF) Q4 2025 Earnings Call Summary

1. Key Financial Results and Metrics

• Q4 Adjusted Earnings: $1.6 billion or $2.49 per share; $2.58 per share excluding notable items (up 24% YoY).
• Full Year Adjusted Earnings: $6 billion or $8.89 per share, reflecting a 10% increase YoY.
• Adjusted Return on Equity (ROE): 16% for the full year, within the target range of 15% to 17%.
• Direct Expense Ratio: Improved to 11.7%, ahead of the five-year target of 11.3%.
• Free Cash Flow: Generated $4.9 billion in 2025, contributing to a five-year target of $25 billion.
• Net Income: Approximately $800 million for Q4 and $3.2 billion for the full year.

2. Strategic Updates and Business Highlights

• New Frontier Strategy: Focused on growth, capital deployment, and operational efficiency. Key initiatives included the acquisition of PineBridge Investments and the establishment of MetLife Investment Management (MIM).
• Group Benefits: Added $100 million in new adjusted premiums and fees; voluntary PFOs increased by 10% YoY.
• Retirement Solutions: Achieved record pension risk transfer (PRT) sales of over $14 billion, the highest annual total.
• International Markets: Asia and Latin America reported strong sales growth, with Asia up 18% and Latin America up 12% in constant currency.
• Capital Management: Returned approximately $4.4 billion to shareholders through stock repurchases and dividends.

3. Forward Guidance and Outlook

• 2026 Expectations:
  • Double-digit adjusted EPS growth.
  • Adjusted ROE between 15% to 17%.
  • Direct expense ratio target of 12.1% due to the PineBridge acquisition.
  • Anticipated favorable investment income of approximately $1.6 billion pretax.
  • Group Benefits adjusted earnings expected to grow 7% to 9%.
  • Retirement Solutions adjusted earnings projected between $1.6 billion and $1.8 billion.
  • MIM expected adjusted earnings of $240 million to $280 million.

4. Bad News, Challenges, or Points of Concern

• Disability Experience: Weaker than expected results due to higher average severity and incidents, although not indicative of a long-term trend.
• Variable Investment Income (VII): Full-year VII of $1.5 billion fell short of the target of $1.7 billion, primarily due to lower returns in real estate.
• Surrender Activity: Increased surrender rates noted in Japan due to currency depreciation, with expectations for normalization in 2026.
• Competitive Pressures: Ongoing macroeconomic volatility in Japan and the potential impact of rising interest rates on sales and persistency.

5. Notable Q&A Insights

• Group Benefits Pricing: Positive renewal results and robust persistency noted, particularly in dental products.
• Japan Market Dynamics: Despite macro volatility, MetLife remains optimistic about its competitive position and sales growth in Japan.
• Reinsurance Strategy: Leveraging reinsurance to augment capital and support liability growth in the retirement market.
• AI Impact: The company is aware of potential employment shifts due to AI but remains confident in its diversified book and growth outlook.
• Dividend Capacity: No constraints anticipated in Japan regarding dividend capacity despite unrealized losses.

This summary encapsulates MetLife's financial performance, strategic initiatives, future outlook, and key concerns, providing a balanced view of the company's current position and expectations.